Although many studies have shown the potential of GLP‐1 RAs for NAFLD, the evidence for the role of GLP‐1 RAs in the management of NASH remains inconclusive. The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatotic liver disease.